Coalition for Sustainable Pharmaceuticals and Medical Devices

The aim of the group is to enable the transition to more sustainable healthcare products and services through promoting best practice and developing sustainability tools and guidelines related to pharmaceuticals and medical devices. 

Objectives

  • To act as a convenor of expertise related to sustainable pharmaceuticals and medicals devices and dissemination of best practise throughout the healthcare system globally.
  • To develop tools and guidelines to achieve more sustainable healthcare products and services through a holistic life cycle sustainability approach.
  • To monitor and update existing tools and guidelines developed by the coalition to ensure their ongoing relevance and applicability.

Leadership Members

AstraZeneca
Baxter Healthcare
Becton Dickinson
Boehringer Ingelheim
GlaxoSmithKline
Johnson & Johnson
Medtronic
MSD
Novo Nordisk
Sustainable Development Unit
    

Advisory Members

Association of British Healthcare Industries (ABHI)
Association of British Pharmaceutical Industries (ABPI)
Barts Health NHS Trust
British Generic Manufacturers Association (BGMA)
Environmental Resources Management (ERM)
Guy’s & St Thomas’ NHS Foundation Trust
Hull and East Yorkshire Hospitals NHS Trust
Medicines and Healthcare products Regulatory Agency (MHRA)
National Institute for Health and Clinical Excellence (NICE)
Pharmaceutical Market Support Group (PMSG)
Royal Pharmaceutical Society
UK Department of Health
United Nations Development Programme (UNDP)  

Current projects

The coalition is developing tools and guidance in such areas as:

  • Carbon footprint guidance for pharmaceuticals and medical devices
  • Guidance to appraise the sustainability of care pathways
 

Further information to be available soon.

Contact

The Sustainable Development Unit acts as the secretariat.  For further information about the coalition please contact the SDU on 0113 8253220 or england.sdu@nhs.net